Cape Biologix Technologies

Cape Biologix Technologies, a subsidiary of Cape Bio Pharms, utilizes plant-based expression platforms to improve the health and well-being of people and animals. We started in 2020 with the mission to contribute to global biosecurity through manufacturing high quality plant-based proteins that are accessible and economical.

Our transient plant-based expression platform provides a compelling competitive alternative to traditional expression platforms through its superior speed, quality, flexibility, scalability, and sustainability.